Hanmi Pharm. Co., Ltd. (128940.KS)
KRW 269500.0
(-1.46%)
KRW 269500.0
(-1.46%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 11.52 Thousand KRW | 76.79% |
| 2022 | 6517.20 KRW | 23.67% |
| 2021 | 5269.74 KRW | 288.1% |
| 2020 | 1357.83 KRW | -66.13% |
| 2019 | 4008.72 KRW | 46.53% |
| 2018 | 2735.74 KRW | -44.9% |
| 2017 | 4965.22 KRW | 166.86% |
| 2016 | 1860.59 KRW | -84.88% |
| 2015 | 12.3 Thousand KRW | 340.49% |
| 2014 | 2793.93 KRW | -22.27% |
| 2013 | 3594.63 KRW | 81.67% |
| 2012 | 1978.67 KRW | 1570.89% |
| 2011 | 118.42 KRW | 110.17% |
| 2010 | -1164.56 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 3175.86 KRW | -26.77% |
| 2024 Q3 | 2756.66 KRW | -23.03% |
| 2024 Q1 | 4336.82 KRW | 56.88% |
| 2023 Q2 | 1101.58 KRW | -67.59% |
| 2023 Q3 | 4311.01 KRW | 291.35% |
| 2023 Q4 | 2764.48 KRW | -35.87% |
| 2023 FY | - KRW | 76.79% |
| 2023 Q1 | 3399.09 KRW | 121.65% |
| 2022 FY | - KRW | 23.67% |
| 2022 Q4 | 1533.55 KRW | -24.73% |
| 2022 Q3 | 2037.51 KRW | 37.74% |
| 2022 Q1 | 1566.54 KRW | 14.06% |
| 2022 Q2 | 1479.29 KRW | -5.57% |
| 2021 Q2 | 559.40 KRW | -62.62% |
| 2021 Q1 | 1496.54 KRW | -35.36% |
| 2021 Q4 | 1373.49 KRW | -25.34% |
| 2021 Q3 | 1839.68 KRW | 228.87% |
| 2021 FY | - KRW | 288.1% |
| 2020 Q2 | 588.01 KRW | -0.64% |
| 2020 Q3 | -2422.71 KRW | -512.02% |
| 2020 Q4 | 2315.18 KRW | 195.56% |
| 2020 FY | - KRW | -66.13% |
| 2020 Q1 | 591.78 KRW | -51.24% |
| 2019 Q2 | 1439.35 KRW | 43.99% |
| 2019 Q4 | 1213.69 KRW | 140.17% |
| 2019 FY | - KRW | 46.53% |
| 2019 Q1 | 999.60 KRW | 255.81% |
| 2019 Q3 | 505.34 KRW | -64.89% |
| 2018 Q2 | 1076.01 KRW | 74.71% |
| 2018 FY | - KRW | -44.9% |
| 2018 Q4 | -641.54 KRW | -169.65% |
| 2018 Q3 | 921.13 KRW | -14.39% |
| 2018 Q1 | 615.90 KRW | -11.79% |
| 2017 Q4 | 698.24 KRW | -57.66% |
| 2017 FY | - KRW | 166.86% |
| 2017 Q2 | 996.30 KRW | -34.04% |
| 2017 Q1 | 1510.44 KRW | 145.94% |
| 2017 Q3 | 1648.96 KRW | 65.51% |
| 2016 FY | - KRW | -84.88% |
| 2016 Q1 | 3114.54 KRW | -76.11% |
| 2016 Q2 | 1601.67 KRW | -48.57% |
| 2016 Q4 | -3287.67 KRW | -961.23% |
| 2016 Q3 | 381.74 KRW | -76.17% |
| 2015 Q2 | 896.60 KRW | -11.13% |
| 2015 FY | - KRW | 340.49% |
| 2015 Q1 | 1008.87 KRW | -4.06% |
| 2015 Q4 | 13.03 Thousand KRW | 712.25% |
| 2015 Q3 | -2129.21 KRW | -337.48% |
| 2014 Q1 | 1132.08 KRW | 33.15% |
| 2014 Q4 | 1051.57 KRW | 1122.61% |
| 2014 Q3 | 86.01 KRW | -85.02% |
| 2014 FY | - KRW | -22.27% |
| 2014 Q2 | 574.17 KRW | -49.28% |
| 2013 Q4 | 850.23 KRW | -24.56% |
| 2013 Q1 | 999.82 KRW | 1.42% |
| 2013 Q3 | 1127.05 KRW | 74.77% |
| 2013 Q2 | 644.86 KRW | -35.5% |
| 2013 FY | - KRW | 81.67% |
| 2012 Q4 | 985.83 KRW | 22.07% |
| 2012 FY | - KRW | 1570.89% |
| 2012 Q2 | 392.45 KRW | 270.91% |
| 2012 Q1 | -229.63 KRW | 76.41% |
| 2012 Q3 | 807.62 KRW | 105.79% |
| 2011 Q3 | -54.95 KRW | -233.02% |
| 2011 Q1 | 129.83 KRW | 116.77% |
| 2011 FY | - KRW | 110.17% |
| 2011 Q2 | 41.31 KRW | -68.18% |
| 2011 Q4 | -973.54 KRW | -1671.68% |
| 2010 FY | - KRW | 0.0% |
| 2010 Q3 | -477.12 KRW | 0.0% |
| 2010 Q4 | -774.18 KRW | -62.26% |